Epsilon Healthcare Ltd. Stock Analysis EPN.AX
Epsilon Healthcare Ltd. manufactures and distributes hydroponics equipment, materials, and nutrients; and develops and delivers medical cannabis. The company is headquartered in Sydney, New South Wales. The company went IPO on 2017-05-04. The firm has a diversified and vertically integrated portfolio of assets, including healthcare, pharmaceutical contract development and manufacturing and pharmacy services. The Company’s segments include Telehealth Medical Practice and Contract Development and Manufacturing. The firm owns medicinal cannabis assets, including the GMP cannabis manufacturing facility in the Southern Hemisphere (the Southport Facility) in Southport, Australia, and the Tetra Health clinic group. Its subsidiaries include Epsilon Pharma Pty Ltd, Metra Holdings Pty Ltd, Epsilon Biotech Pty Ltd, among others.
Read More Epsilon Healthcare Ltd (EPN.AX) Chart
Key Statistics of Epsilon Healthcare Ltd (EPN.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.02Volume
575.01KP/E Ratio (TTM)
-52 Week Range
Market Cap
7.78MAvg. Volume
42.34KDividend Yield
-Financial Metrics & Statements of Epsilon Healthcare Ltd (EPN.AX)
FAQ's for Epsilon Healthcare Ltd (EPN.AX)
- According to Musaffa’s Shariah screening methodology, Epsilon Healthcare Ltd (EPN.AX) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.